Individual Postdoctoral Fellowship (F32)

Individual Postdoctoral Fellowship (F32) is sponsored by AHRQ. This opportunity supports mission-aligned projects and measurable outcomes.

Expired PA-22-251: Agency for Healthcare Research and Quality (AHRQ)-sponsored National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32) This notice has expired. For NIH, in limited situations, applications may be accepted on a case-by-case basis for a short period after expiration to accommodate NIH late or continuous submission policies . Contact the eRA Service Desk for any submission issues.

Check the NIH Guide for active opportunities and notices. Department of Health and Human Services Part 1. Overview Information Participating Organization(s) Agency for Healthcare Research and Quality ( AHRQ ) NOTE: The policies, guidelines, terms, and conditions stated in this announcement may differ from those used by the NIH.

Where this Notice of Funding Opportunity (NOFO) provides specific written guidance that may differ from the general guidance provided in the grant application form, please follow the instructions given in this NOFO. Also note that AHRQ has different page limits than NIH for the application Research Strategy, which can be found within each individual NOFO.

of Participating Organizations Office of Extramural Research, Education and Priority Notice of Funding Opportunity Title Agency for Healthcare Research and Quality (AHRQ)-sponsored National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32) Postdoctoral Individual National Research Service Award March 31, 2025 - This funding opportunity was updated to align with agency priorities.

Carefully reread the full funding opportunity and make any needed adjustments to your application prior to submission. April 04, 2024 - Overview of Grant Application and Review Changes for Due Dates on or after January 25, 2025. See Notice NOT-OD-24-084 January 11, 2023 - AHRQ Announces Interest in Research on Climate Change and Healthcare.

See Notice NOT-HS-23-006 NOT-OD-23-012 Reminder: FORMS-H Grant Application Forms and Instructions Must be Used for Due Dates On or After January 25, 2023 - New Grant Application Instructions Now Available NOT-OD-22-018- Reminder: FORMS-G Grant Application Forms & Instructions Must be Used for Due Dates On or After January 25, 2022 - New Grant Application Instructions Now Available Limitation on AHRQ FY2022 Grants, Cooperative Agreements, and Contracts NOT-OD-21-109 - Expanding Requirement for eRA Commons IDs to All Senior/Key Personnel Changes to the Biographical Sketch and Other Support Format Page for Due Dates on or after May 25, 2021 of Updated AHRQ Policy for Late Application Submission for Active Peer Review or National Advisory Council Service Policy on the Inclusion of Priority Populations in Research Special Emphasis Notice (SEN): AHRQ Announces Interest in Health Services Research to Advance Health Equity Guide Notice on Exception to the Use of the Single IRB Review Requirements During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency NOT-OD-21-095 - Extending the Special Exception to the NIH/AHRQ/NIOSH Post-Submission Material Policy During the COVID-19 Pandemic: January 2022 Council Agency for Healthcare Research and Quality Data Management Plan Policy Guide Notice on Implementation of the Use of a Single Institutional Review Board (IRB) for Cooperative Research at 45 CFR 46.

114 (b) Announces Change in Grant Recipient Purchasing of Identifiable CMS Data, Multiple Program Director/Principal Investigator Policy NOT-OD-17-094 - Clarification and Update: Salary Supplementation and Compensation on Research Career NOT-OD-22-190 - Adjustments to NIH and AHRQ Grant Application Due Dates Between September 22 and Notice of Funding Opportunity (NOFO) Number Companion Funding Opportunity Additional Information on Eligibility .

Assistance Listing Number(s) Funding Opportunity Purpose The purpose of this individual postdoctoral research training fellowship is to enhance the research training of promising postdoctoral candidates who have the potential to become productive, independent investigators in health services research, with a research interest in areas and priorities relevant to the mission of AHRQ.

This Notice of Funding Opportunity (NOFO) does not allow applicants to propose to lead an independent clinical trial but does allow applicants to propose research experience in a clinical trial led by a sponsor or co-sponsor . Open Date (Earliest Submission Date) Letter of Intent Due Date(s) AHRQ F32: April 8, August 8, and December 8, annually.

All applications are due, by 5:00 PM local time of Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

AIDS Application Due Date(s) Generally, four months after the receipt date Not Applicable for Fellowships Generally, up to five months (for December and April submission dates) and up to eight months (for August submission date) after the It is critical that applicants follow the instructions in Fellowship SF424 (R&R) Application Guide except where instructed to do otherwise (in this NOFO or in a Notice from the NIH Guide for Grants and Contracts).

Conformance to all requirements (both in the Application Guide and the NOFO) is required and strictly enforced. Applicants must read and follow all application instructions in the Application Guide as well as any program-specific instructions noted in Section IV , and follow the AHRQ Grants Policy and Guidance found on the AHRQ website at http://www. ahrq.

gov/funding/policies/NOFOguidance/index. html . When the program-specific instructions deviate from those in the Application Guide, follow the program-specific instructions.

Applications that do not comply with these instructions may be delayed or not accepted for review. There are several options available to submit your application through Grants. gov to NIH and Department of Health and Human Services partners.

You must use one of these submission options to access the application forms for this opportunity. Part 1. Overview Information Part 2.

Full Text of the Announcement Section I. Funding Opportunity Description Section II. Award Information Section III.

Eligibility Information Section IV. Application and Submission Section V. Application Review Information Section VI.

Award Administration Information Section VII. Agency Contacts Section VIII. Other Information Full Text of Announcement Section I.

Funding Opportunity The overall goal of the Agency for Healthcare Research and Quality (AHRQ)-sponsored Ruth L. Kirschstein National Research Service Award program is to help ensure that a diverse pool of highly trained scientists is available in appropriate scientific disciplines to address the Nation's health services research and behavioral research needs. More information about NRSA programs may be found at the Ruth L.

Kirschstein National Research Service Award (NRSA) website. The purpose of the Agency for Healthcare Research and Quality-sponsored Ruth L. Kirschstein National Research Service Award Individual Postdoctoral Fellowship is to support promising applicants during their mentored postdoctoral training under the guidance of outstanding faculty sponsors.

The integrated program of research and training should enhance the individual's potential to develop into a productive, independent researcher. The training plan should document the need for, and the anticipated value of, the proposed mentored training in relationship to the individual's research career goals. The training plan should also facilitate the fellow's transition to the next stage of their career.

Applications for research fellowship grants must be responsive to AHRQ's mission, which is to produce evidence to make health care safer, higher quality, more accessible, equitable and affordable, and to work within HHS and with other partners to make sure that the evidence is understood AHRQ welcomes fellowship training applications in any area of health services research relevant to AHRQ's priority areas.

AHRQ research priority areas are described at http://www. ahrq. gov/funding/policies/NOFOguidance/index.

html . Applicants are strongly encouraged to focus on topical areas unique to AHRQ, demonstrating how expected results can be used or made available for use to improve healthcare outcomes and quality. Results should be directly relevant to customers, such as providers and practitioners, administrators, payers, consumers, policymakers, and insurers.

Fellows must focus their research development and projects on health care delivery in the United States.

It is expected that the mentored training experience will A strong foundation in research design, methods, and analytic techniques appropriate to the proposed research; Enhanced ability to conceptualize and think through research problems with increasing independence; Experience conducting research using appropriate, state-of-the-art methods, as well as presenting and publishing the research findings as first author; The opportunity to interact with members of the scientific community at appropriate scientific meetings and workshops; Skills needed to transition to the next stage of the applicant's The opportunity to enhance the applicant's understanding of the health-related sciences and the relationship of their research to health and Promoting equity is an important societal goal.

AHRQ intends that research funded by the agency contribute to this goal by addressing equity. Fellowship applicants are encouraged to include a focus on the reduction of disparities in healthcare outcomes and quality underserved populations in their research training.

Applicants with a health professional doctoral degree may use the proposed postdoctoral training to satisfy a portion of the degree requirements for a master's degree, a research doctoral degree or any other advanced research degree program. The NRSA F32 award may provide up to three years of support for postdoctoral research training.

The AHRQ encourages applications from individuals sufficiently early in their postdoctoral training period that they can benefit from the mentored research and training opportunities of an individual fellowship award. Information for award authorities and regulations. Section II.

Award Information Grant: A support mechanism providing money, property, or both to an eligible entity to carry out an approved project or activity. Application Types Allowed Glossary and the SF424 (R&R) Application Guide provide details on these application types. Only those application types listed here are allowed Not Allowed: Only accepting applications that do not propose independent clinical trials.

Note: Applicants may propose to gain experience in a clinical trial led by a sponsor/co-sponsor as part of their research help determining whether you are doing a clinical trial? Funds Available and Anticipated Number of Awards Funding for this program is provided by the National Research Service Award (NRSA) program.

The number of awards is contingent upon availability of NRSA funds, and the submission of a sufficient number of meritorious applications. Award budgets are composed of stipends, tuition and fees, and institutional allowance, as described below.

Individuals may receive up to 3 years of aggregate NRSA support at the postdoctoral level, including any combination of support from institutional training grants (e.g., T32) and an individual fellowship award. NRSA awards provide stipends as a subsistence allowance to help defray living expenses during the research and clinical training experiences. See https://researchtraining.

nih. gov/resources/policy-notices For postdoctoral fellows, costs associated with tuition and fees are allowable only if they are required for specific courses in support of the research training, or a formal degree-granting program. AHRQ will contribute to the combined cost of tuition and fees at the rate in place at the time of award.

See https://researchtraining. nih. gov/resources/policy-notices .

The application should request the appropriate NRSA institutional allowance to help defray the cost of fellowship expenses such as health insurance, research supplies, equipment, books, and travel to scientific meetings. See https://researchtraining. nih.

gov/resources/policy-notices . Indirect costs are not allowed on individual fellowship Stipend levels, as well as funding amounts for tuition and fees and the institutional allowance are announced annually in the NIH Guide for Grants and Contracts, and are also posted on the Ruth L. Kirschstein National Research Service Award (NRSA) webpage .

These projects are being funded pursuant to 42 U.S.C. 299a(b)(1), which provides that AHRQ may provide training grants in the field of health services research. All applications submitted and AHRQ grants made in response to this NOFO are subject to 45 CFR Part 75 (Uniform Administrative Requirements, Cost Principles and Audit Requirements for HHS Awards; http://www.

ecfr. gov/cgi-bin/text-idx? node=pt45.

1. 75 ) , the HHS Grants Policy Statement (see http://www. ahrq.

gov/funding/policies/hhspolicy/index. html ), and the terms and conditions set forth in the Notice of Award.

Higher Education Institutions Public/State Controlled Institutions of Higher Education Private Institutions of Higher Education The following types of Higher Education Institutions are always encouraged to apply for AHRQ support as Public or Private Institutions of Higher Education: Hispanic-serving Institutions Historically Black Colleges and Universities (HBCUs) Tribally Controlled Colleges and Universities (TCCUs) Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Nonprofits Other Than Institutions of Higher Education Nonprofits with 501(c)(3) IRS Status (Other than Institutions of Nonprofits without 501(c)(3) IRS Status (Other than Institutions AHRQ's authorizing legislation does not allow for-profit organizations to be eligible to lead applications under this research mechanism.

For-profit organizations may participate in projects as members of consortia or as subcontractors only. Applications submitted by for-profit organizations or foreign institutions will not be reviewed. Organizations described in section 501(c) 4 of the Internal Revenue Code that engage in lobbying are not eligible.

HHS grants policy requires that the grant recipient perform a substantive role in the conduct of the planned project or program activity and not merely serve as a conduit of funds to another party or parties.

If consortium/contractual activities represent a significant portion of the overall project, the applicant must justify why the applicant organization, rather than the party(s) performing this portion of the overall project, should be the recipient and what substantive role the applicant organization will play.

Justification can be provided in the Specific Aims or Research Strategy section of the PHS398 Research Plan Component sections of the SF424 (R&R) application. There is no budget allocation guideline for determining substantial involvement; determination of substantial involvement is based on a review of the primary project activities for which grant support is provided and the organization(s) that will be performing those activities.

Before submitting a fellowship application, the applicant must identify a sponsoring institution. The sponsoring institution must have staff and facilities available on site to provide a suitable environment for performing high-quality research training. The training should occur in an environment that has appropriate human and technical resources and is demonstrably committed to training in the field(s) proposed by the applicant.

The sponsoring institution may be private (nonprofit) or public. All eligible institutions with the appropriate resources and commitment are encouraged to apply. The NRSA F32 fellowship is designed to support research training experiences in new settings in order to maximize the acquisition of new skills and knowledge.

In most cases, therefore, the sponsoring institution should be a site other than where the applicant trained as a graduate student.

However, if the applicant is proposing postdoctoral training at their doctoral institution, the application must carefully document the opportunities for new research training experiences specifically designed to broaden their scientific background and to acquire new knowledge and/or technical skills that will enhance their potential to become a productive, independent investigator.

Non-domestic (non-U.S.) Entities (Foreign Institutions) are Non-domestic (non-U.S.) components of U.S. Organizations are Foreign components, as defined in the HHS Grants Policy Statement may participate in projects as member of consortia or as Applicant organizations must complete and maintain the following registrations as described in the SF 424 (R&R) Application Guide to be eligible to apply for or receive an award.

All registrations must be completed prior to the application being submitted. Registration can take 6 weeks or more, so applicants should begin the registration process as soon as Award Management (SAM) Applicants must complete and maintain an active requires renewal at least annually . The renewal process may require as much time as the initial registration.

SAM registration includes the assignment of a Commercial and Government Entity (CAGE) Code for domestic organizations which have not already been assigned a CAGE Code. Commercial and Government Entity (NCAGE) Code Foreign organizations must obtain an NCAGE code (in lieu of a CAGE code) in order to register in SAM. Unique Entity Identifier (UEI)- A UEI is issued as part of the SAM.

gov registration process. The same UEI must be used for all registrations, as well as on the grant application. Commons - Once the unique organization identifier is established, organizations can register with eRA Commons in tandem with completing their full SAM and Grants.

gov registrations; all registrations must be in place by time of submission. eRA Commons requires organizations to identify at least one Signing Official (SO) and at least one Program Director/Principal Investigator (PD/PI) account in order to submit an application. Applicants must have an active SAM registration in order to complete the Program Directors/Principal Investigators (PD/PI) All PD/PI must have an eRA Commons account.

PD/PI should work with their organizational officials to either create a new account or to affiliate their existing account with the applicant organization in eRA Commons. If the PD/PI is also the organizational Signing Official, they must have two distinct eRA Commons accounts, one for each role. Obtaining an eRA Commons account can take up to 2 weeks.

All PD/PI must be registered with ORCiD . The personal profile associated with the PD/PI eRA Commons account must be linked to a valid ORCID ID. For more information on linking an ORCID ID to an eRA Commons personal profile see the ORCID topic in our eRA Commons online help .

Eligible Individuals (Program Director/Principal Investigator) Any applicant fellow with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director/Principal Investigator (PD/PI) is invited to work with their sponsor and organization to develop an application for support.

Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for AHRQ support. Multiple PDs/PIs are not allowed.

By the time of award, the individual must be a citizen or a non-citizen national of the United States or have been lawfully admitted for permanent residence (i.e., possess a currently valid Permanent Resident Card USCIS Form I-551, or other legal verification of such status). The applicant must show evidence of high academic performance, and commitment to a research career.

Before an Agency for Healthcare Research and Quality (AHRQ)-sponsored Ruth L. Kirschstein National Research Service Award (NRSA) postdoctoral fellowship can be activated, the individual must have received a PhD, MD, DO, DC, DDS, DVM, OD, DPM, ScD, EngD, DrPH, DNSc, ND (Doctor of Naturopathy), PharmD, DSW, PsyD, or equivalent doctoral degree from an accredited domestic or foreign institution.

Certification by an authorized official of the degree-granting institution that all degree requirements have been met is also acceptable. An Agency for Healthcare Research and Quality (AHRQ)-sponsored Ruth L. Kirschstein National Research Service Award (NRSA) fellowship may not be used to support the clinical years of residency training.

However, these awards are appropriate for the research fellowship years of a residency program. Research clinicians must devote full-time to their proposed research training and confine clinical duties to those activities that are part of the research This NOFO does not require cost sharing.

While there is no cost sharing requirement included in this NOFO, AHRQ welcomes applicant institutions, including any collaborating institutions, to devote resources to this effort. An indication of institutional support from the applicant and its collaborators indicates a greater potential of success and sustainability of the project.

Examples of institutional support would include: donated equipment and space, institutional funded staff time and effort, or other resource investments. Applicant institutions that plan to provide support should indicate institutional support by outlining the specific contributions to the project and providing assurances that their organization and any collaborators are committed to providing these funds and resources to the project.

This can be included at the end of the budget justification section of the application, but institutional support dollars are not to be included in the detailed budget request. 3. Additional Information on Eligibility Applicant organizations may submit more than one application, provided that each application is programmatically distinct.

An individual may not have more than one competing NIH or AHRQ fellowship application pending review concurrently. Resubmission(s): Applicants may submit one resubmission application, but such application must include an Introduction addressing issues raised in the previous critique (Summary Statement). Renewals: Awards are not renewable and are not transferable from one PD/PI to another.

AHRQ will not accept duplicate or highly overlapping applications under review at the same time. This means that the AHRQ will A new (A0) application that is submitted before issuance of the summary statement from the review of an overlapping new (A0) or resubmission A resubmission (A1) application that is submitted before issuance of the summary statement from the review of the previous new (A0) application.

An application that has substantial overlap with another application pending appeal of initial peer review Individuals may not exceed the aggregate limit of NRSA support shown above in the Award Project Period (see Section II. Award Information). Candidates must consider any prior NRSA research training in determining the duration of support requested.

Information regarding previous Kirschstein-NRSA support must be included in the application and will be considered at the time of award. At the time of award and for the duration of the award, individuals are required to pursue their research training on a full-time basis, normally defined as 40 hours per week or as specified by the sponsoring institution in accordance with its own consistently applied policies.

Before submitting the application, the applicant fellow must identify a sponsor(s) (also called mentor) who will supervise the proposed mentored training experience. The sponsor should be an active investigator in the area of the proposed research training and be committed both to the applicant's research training and to direct supervision of their research.

The sponsor must document the availability of sufficient research funds and facilities for high-quality research training. The sponsor, or a member of the sponsor team, should have a successful track record of mentorship. Applicants are encouraged to identify more than one sponsor, i.e., a sponsor team, if this is deemed advantageous for providing expert advice in all aspects of the training program.

When there is a sponsor team, one individual must be identified as the primary sponsor, and will be expected to coordinate the applicant's overall training. The applicant must work with the sponsor(s) in preparing the application. and Submission Information The application forms package specific to this opportunity must be accessed through ASSIST, Grants.

gov Workspace or an institutional system-to-system solution. Links to apply using ASSIST or Grants. gov Workspace are available in Part 1 of this NOFO.

See your administrative office for instructions if you plan to use an institutional system-to-system solution. 2. Content and Form of Application Submission It is critical that applicants follow the Fellowship (F) instructions (R&R) Application Guide , except where instructed in this Notice of Funding Opportunity to do otherwise.

Conformance to the requirements in the Application Guide is required and strictly enforced. Applications that are out of compliance with these instructions may be delayed or not accepted for review. All page limitations described in the SF424 (R&R) Application Guide and the Table of Page Limits must be followed.

for Application Submission The following section supplements the instructions found in the SF424 (R&R) Application Guide and should be used for preparing an application to this NOFO.

All instructions in the SF424 (R&R) Application Guide SF424(R&R) Project/Performance Site Locations All instructions in the SF424 (R&R) Application Guide Other Project Information All instructions in the SF424 (R&R) Application Guide SF424(R&R) Senior/Key Person Profile Expanded All instructions in the SF424 (R&R) Application Guide IMPORTANT REMINDER: The personal profile associated with the eRA Commons username entered in the Credential field for the PD/PI (fellowship applicant) must include an ORCID ID.

For more information on linking an ORCID ID to an eRA Commons personal profile see the ORCID topic in our eRA Commons online help .

PHS Fellowship Supplemental Form The PHS Fellowship Supplemental Form is comprised of the Sponsor(s), Collaborator(s), and Consultant(s) Institutional Environment & Commitment to Training Other Research Training Plan Sections All instructions in the SF424 (R&R) Application Guide must be followed, with the following additional instructions: Fellowship Applicant Section Background and Goals for Fellowship Training candidate’s overall training plan, i.e., the activities planned under this award, should be individually tailored and well-integrated with their research project.

Describe the skills and techniques that the candidate intends to learn as well as any planned, non-research activities (e.g., those relating to professional development and clinical activities) during the award period.

The candidate should provide a timeline for the entire duration of the fellowship Identify the skills, theories, conceptual approaches, etc., to be learned or enhanced during the award, including, as applicable, expertise in rigorous research design, experimental methods, quantitative approaches, and data analysis and interpretation, as applicable.

Research Training Plan Section All instructions in the SF424 (R&R) Application Guide must be followed, including the following instructions for the Research Explain the importance of the problem or critical barrier to progress that the proposed project addresses.

Describe the strengths and weaknesses in the rigor of the prior research (both published and unpublished) that serves as the key support for Explain how the proposed project will improve scientific knowledge, technical capability, and/or clinical practice in one or more broad Describe how the concepts, methods, technologies, treatments, services, or preventative interventions that drive this field will be changed if the proposed aims are achieved.

If the applicant is proposing to gain experience in a clinical trial as part of his or her research training, describe the relationship of the proposed research project to the clinical trial.

Sponsor(s), Collaborator(s), and All instructions in the SF424 (R&R) Application Guide must be followed, with the following additional instructions: If the applicant is proposing to gain experience in a clinical trial as part of his or her research training, the sponsor or co-sponsor must include a statement to document leadership of the clinical trial including source of funding, NCT# and appropriate expertise to guide the applicant in any proposed clinical trials research experience.

The individual receiving support for the clinical trial (i.e., the sponsor/primary mentor or a co-sponsor) is the responsible individual of record for oversight of the trial though fellows can take part in all components of a clinical trial.

Oversight includes (but is not limited to): interacting with relevant Institutional Review Board (IRB) staff; reviewing all informed consent documents; reporting potential serious adverse events; and maintaining responsibility for patient safety. However, the fellow can gain experience in all these components in conjunction with the mentor or individual leading the trial.

The Sponsor should also describe the roles and responsibilities that both they and the fellow are undertaking, including contributions to the research plan, the portion of the research ideas and plan that originated with the candidate, and the relationship between the proposed research plan and funded or unfunded research projects previously devised by the Limited items are allowed in the Appendix.

Follow all instructions for the Appendix as described in the SF424 (R&R) Application Guide; any instructions provided here are in addition to the SF424 (R&R) Application Guide instructions.

Subjects and Clinical Trials Information When involving human subjects research, clinical research, and/or AHRQ clinical trials (and when applicable, clinical trials research experience) follow all instructions for the PHS Human Subjects and Clinical Trials Information form in the SF424 (R&R) Application Guide, with the following additional instructions: If you answered Yes to the question Are Human Subjects Involved?

on the R&R Other Project Information form, you must include at least one human subjects study record using the Study Record: PHS Human Subjects and Clinical Trials Information form or a Delayed Record: PHS Human Subjects and Clinical Trials Information All instructions in the SF424 (R&R) Application Guide Do not provide an NCT# in Section 1, item 1. 5. See instruction for Sponsor(s), Collaborator(s), and Consultant(s) above.

Do not complete Section 4 Protocol Synopsis information or Section 5 Other Clinical Trial-related Attachments. onset does NOT apply to a study that can be described but will not start immediately (i.e., delayed start).

All instructions in the SF424 (R&R) Application Guide PHS Assignment Request Form All instructions in the SF424 (R&R) Application Guide Applicants must carefully follow the SF424 (R&R) Application Guide, including the time period for when reference letters will be accepted . Applications lacking the appropriate required reference letters will not be reviewed. This is a separate process from submitting an application electronically.

Reference letters are submitted directly through the eRA Commons Submit Reference Letter link and not through Grants. gov. 3. Unique Entity Identifier and System for Award See Part 1.

Section III. 1 for information regarding the requirement for obtaining a unique entity identifier and for completing and maintaining active registrations in System for Award Management (SAM), NATO Commercial and Government Entity (NCAGE) Code (if applicable), eRA Commons, and 4. Submission Dates and Times Part I.

Overview Information contains information about Key Dates and times. Applicants are encouraged to submit applications before the due date to ensure they have time to make any application corrections that might be necessary for successful submission. When a submission date falls on a weekend or Federal holiday , the application deadline is automatically extended to the next Organizations must submit applications to Grants.

gov (the online portal to find and apply for grants across all Federal agencies). Applicants must then complete the submission process by tracking the status of the application in the eRA Commons , NIH’s electronic system for grants administration. NIH and Grants.

gov systems check the application against many of the application instructions upon submission. Errors must be corrected and a changed/corrected application must be submitted to Grants. gov on or before the application due date and time.

If a Changed/Corrected application is submitted after the deadline, the application will be considered late. Applications that miss the due date and time are subjected to the NIH Policy on Late Application Submission. are responsible for viewing their application before the due date in the eRA Commons to ensure accurate and successful submission.

Information on the submission process and a definition of on-time submission are provided in the SF424 (R&R) Application Guide. 5. Intergovernmental Review This initiative is not subject to intergovernmental For efficient grant administration, AHRQ grant administration procedures will be used and conducted in accordance with the terms and conditions, cost principles, and other considerations described in the HHS Grants Policy Statement.

The Grants Policy Statement can be found at https://www. ahrq. gov/funding/policies/hhspolicy/index.

html . Research Service Award (NRSA) policies apply to this program. See also F32 webpage.

Pre-award costs are not allowable. Concurrent Awards: A NRSA appointment may not be held concurrently with another federally sponsored fellowship, traineeship, or similar Federal award that provides stipend or otherwise duplicates provisions Requirements and Information Applications must be submitted electronically following the instructions described in the SF424 (R&R) Application Guide. Paper applications will not be accepted.

Applicants must complete all required registrations before the application due